Infective Endocarditis Related to Unusual Microorganisms: A Prospective Population-Based Study
Open Access
- 13 April 2020
- journal article
- research article
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 7 (5), ofaa127
- https://doi.org/10.1093/ofid/ofaa127
Abstract
Increased access to heart valves through early surgery and progress in molecular microbiology have reduced the proportion of infective endocarditis (IE) with no microbiological documentation and increased the proportion of IE associated with unusual microorganisms. We performed an ancillary study of a large prospective population-based survey on IE. Unusual-microorganism IE was defined as definite IE (Duke-Li criteria) due to microorganisms other than streptococci, staphylococci, or enterococci. Of 471 cases of documented IE, 46 (9.8%) were due to unusal microorganisms; the following were involved in >1 case: Candida albicans (n = 4), Cutibacterium acnes (n = 4), Pseudomonas aeruginosa (n = 3), Cardiobacterium hominis (n = 3), and Coxiella burnetii (n = 2). Cases were documented with blood cultures (n = 37, 80.4%), heart valve polymerase chain reaction (PCR; n = 5), heart valve culture (n = 2), PCR on vertebral biopsy (n = 1), or serology (n = 1). As compared with IE due to staphylococci, streptococci, or enterococci (n = 420), IE due to unusual microorganisms occurred more frequently in patients with previously known heart disease (69.0% vs 44.3%; P = .002), prosthetic valve (40.5% vs 18.1%; P = .0006), longer duration of fever (mean, 35.1 ± 46.8 days vs 12.5 ± 17.8; P = .003), and who were more often nosocomial (38.1% vs 20.2%; P = .02). In this population-based study, 9.8% of IE cases were due to unusual microorganisms, with a predominance of anaerobes, yeast, and gram-negative bacilli. As compared with IE related to staphylococci, streptococci, or enterococci, IE cases related to unusual microorganisms were associated with previously known heart disease, prosthetic valve, longer duration of fever, and nosocomial acquisition. ORCID 0000-0003-3617-5411Funding Information
- French Ministry of Health
- Société Française de Cardiologie
- European Society of Clinical Microbiology and Infectious Diseases
- Novartis
This publication has 23 references indexed in Scilit:
- HACEK Infective Endocarditis: Characteristics and Outcomes from a Large, Multi-National CohortPLOS ONE, 2013
- Preeminence of Staphylococcus aureus in Infective Endocarditis: A 1-Year Population-Based SurveyClinical Infectious Diseases, 2012
- Comprehensive Diagnostic Strategy for Blood Culture–Negative Endocarditis: A Prospective Study of 819 New CasesClinical Infectious Diseases, 2010
- Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): The Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC)European Heart Journal, 2009
- Clinical Presentation, Etiology, and Outcome of Infective Endocarditis in the 21st CenturyJAMA Internal Medicine, 2009
- Emerging Data Indicating that Extended Incubation of Blood Cultures Has Little Clinical ValueClinical Infectious Diseases, 2005
- Blood Culture-Negative Endocarditis in a Reference CenterMedicine, 2005
- Endocarditis Due to Rare and Fastidious BacteriaClinical Microbiology Reviews, 2001
- Proposed Modifications to the Duke Criteria for the Diagnosis of Infective EndocarditisClinical Infectious Diseases, 2000
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987